Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced appointments to the dermatology leadership team of Michael McMyne, who has joined as vice president of Sales, and Stacey Williams, who has joined as vice president of Marketing. Additionally, the company announced Lainie Keller has joined as vice president of Corporate Communications.
New Leadership Team Members Bolster Valeant Dermatology
In his new role, McMyne will be responsible for t...